Related Experiment Video

Updated: Feb 13, 2026

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
12:04

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Published on: August 14, 2012

29.5K

Novel Treatment of Small-Cell Neuroendocrine of the Vagina

Kathryn Kostamo1, Mishka Peart1, Nathalie McKenzie2

  • 1Department of Obstetrics and Gynecology, Orlando Regional Healthcare, Orlando, FL, USA.

Case Reports in Oncological Medicine
|March 15, 2018
PubMed
Abstract

Insights

Gene expression profiling for rare vaginal small-cell neuroendocrine carcinoma may improve patient outcomes. This approach guided treatment, potentially extending progression-free survival (PFS) in a challenging case.

Area of Science:

  • Gynecologic Oncology
  • Oncology
  • Translational Research

Background:

  • Primary vaginal small-cell neuroendocrine carcinoma is a rare, aggressive cancer with poor prognosis.
  • Current multimodal therapies have limited efficacy, with high mortality rates within one year.
  • Gene expression profiling offers potential insights for personalized cancer treatment.

Observation:

  • A case study of a 34-year-old woman with primary vaginal small-cell neuroendocrine carcinoma is presented.
  • The patient experienced recurrence 20 weeks post-diagnosis.
  • Treatment was initiated based on tumor tissue gene expression profiling results.

Findings:

  • The patient achieved a 14-month progression-free survival (PFS).
  • She survived for 34 months post-initial visit.
  • Gene expression profiling informed the chemoradiation strategy.

Implications:

  • Gene expression profiling may be a valuable tool in managing vaginal small-cell neuroendocrine carcinoma.
  • This approach could potentially improve progression-free survival in patients.
  • Further research is warranted to validate these findings in a larger cohort.

More Related Videos

Tissue Processing and Isolation of Primary Fibroblasts from the Human Vagina08:30

Tissue Processing and Isolation of Primary Fibroblasts from the Human Vagina

Published on: November 22, 2024

1.0K
Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip08:15

Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip

Published on: February 16, 2024

3.4K

Related Concept Videos

Vagina01:26

Vagina

The vaginal canal is a tubular structure averaging about 10 cm in length that acts as the entryway to the female reproductive system and the passageway for menstrual flow and childbirth. The interior walls of the vagina exhibit concentric folds called rugae and are topped by an area known as the fornix, which connects with the protruding cervical portion of the uterus. This canal is comprised of an external fibrous layer, a muscular middle layer, and an inner lining with mucosal rugae, which...
35.3K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
976
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K